Clinical trials
Pulmonary Arterial Hypertension trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Withdrawn | 5 |
| Recruiting | 3 |
| Active, not recruiting | 3 |
| Terminated | 1 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Cleveland Clinic | 3 |
| Vanderbilt University Medical Center | 3 |
| University of California, Los Angeles | 2 |
| University of Pennsylvania | 2 |
| Aria CV, Inc | 1 |
| Columbia University | 1 |
| Inova Health Care Services | 1 |
| Massachusetts General Hospital | 1 |
| Mayo Clinic | 1 |
| Medtronic Cardiac Rhythm and Heart Failure | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Arterial Hypertension | 25 |
| Hypertension, Pulmonary | 4 |
| Familial Primary Pulmonary Hypertension | 2 |
| Congenital Abnormalities | 1 |
| Eisenmenger Complex | 1 |
| Frailty | 1 |
| Heart Defects, Congenital | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.